Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality
Abstract Introduction Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with takotsubo cardiomyopathy, recent studies have demonstrated the long-lasting functional impairment in those patients. Purpose We sought to evaluate the pred...
Gespeichert in:
Veröffentlicht in: | European heart journal 2020-11, Vol.41 (Supplement_2) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | Supplement_2 |
container_start_page | |
container_title | European heart journal |
container_volume | 41 |
creator | Matsushita, K Lachmet-Thebaud, L Marchandot, B Sato, C Dagrenat, C Greciano, S De Poli, F Leddet, P Trimaille, A Heger, J Reydel, A Trinh, A Ohlmann, P Jesel, L Morel, O |
description | Abstract
Introduction
Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with takotsubo cardiomyopathy, recent studies have demonstrated the long-lasting functional impairment in those patients.
Purpose
We sought to evaluate the predictors of incomplete recovery in chronic phase and its impact on cardiovascular mortality after takotsubo cardiomyopathy.
Methods
Patients with takotsubo cardiomyopathy between 2008 and 2018 were retrospectively enrolled in three different institutions. Takotsubo cardiomyopathy was diagnosed according to the European Society of Cardiology Heart Failure Association criteria. After exclusion of in-hospital deaths, 407 patients were split into 2 subgroups according whether their LVEF were >50% (recovery group; n=333), or ≤50% (incomplete recovery group; n=74) at follow-up. The primary endpoint was the impact of incomplete recovery on cardiovascular mortality.
Results
Patients with incomplete recovery were more likely to be male, to have dementia, pacemaker, and supraventricular arrhythmia. C-reactive protein (CRP) levels on admission, at peak, and at discharge were significantly higher in patients with incomplete recovery. By multivariate logistic regression analysis, lower EF at discharge (odds ratio [OR]: 0.91; 95% confidence interval [CI]: 0.88 to 0.95; p |
doi_str_mv | 10.1093/ehjci/ehaa946.1184 |
format | Article |
fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ehjci_ehaa946_1184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ehjci/ehaa946.1184</oup_id><sourcerecordid>10.1093/ehjci/ehaa946.1184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c814-163a045f2809ab22648c34c0e53b57831a050b9d7ce8b90ff69c727ec2992b673</originalsourceid><addsrcrecordid>eNqNkE1OwzAUhC0EEqVwAVa-QMqzYzv2ElX8VKrEpgt20bPjqClJHdlupdyelvYAbGY2883iI-SZwYKBKV_8due6UyIaoRaMaXFDZkxyXhgl5C2ZATOyUEp_35OHlHYAoBVTM2JXexeGsffZ0-hdOPo40dDSjD8hp4MN1GFsujBMYcS8nWiXKNIBdyHS5gTFodvjPp-Ry_CIyR16jHQIMWPf5emR3LXYJ_907TnZvL9tlp_F-utjtXxdF04zUTBVIgjZcg0GLedKaFcKB16WVla6ZAgSrGkq57U10LbKuIpX3nFjuFVVOSf8cutiSCn6th5jN2Ccagb1WVL9J6m-SqrPkk5QcYHCYfzP_hdJH243</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Matsushita, K ; Lachmet-Thebaud, L ; Marchandot, B ; Sato, C ; Dagrenat, C ; Greciano, S ; De Poli, F ; Leddet, P ; Trimaille, A ; Heger, J ; Reydel, A ; Trinh, A ; Ohlmann, P ; Jesel, L ; Morel, O</creator><creatorcontrib>Matsushita, K ; Lachmet-Thebaud, L ; Marchandot, B ; Sato, C ; Dagrenat, C ; Greciano, S ; De Poli, F ; Leddet, P ; Trimaille, A ; Heger, J ; Reydel, A ; Trinh, A ; Ohlmann, P ; Jesel, L ; Morel, O</creatorcontrib><description>Abstract
Introduction
Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with takotsubo cardiomyopathy, recent studies have demonstrated the long-lasting functional impairment in those patients.
Purpose
We sought to evaluate the predictors of incomplete recovery in chronic phase and its impact on cardiovascular mortality after takotsubo cardiomyopathy.
Methods
Patients with takotsubo cardiomyopathy between 2008 and 2018 were retrospectively enrolled in three different institutions. Takotsubo cardiomyopathy was diagnosed according to the European Society of Cardiology Heart Failure Association criteria. After exclusion of in-hospital deaths, 407 patients were split into 2 subgroups according whether their LVEF were >50% (recovery group; n=333), or ≤50% (incomplete recovery group; n=74) at follow-up. The primary endpoint was the impact of incomplete recovery on cardiovascular mortality.
Results
Patients with incomplete recovery were more likely to be male, to have dementia, pacemaker, and supraventricular arrhythmia. C-reactive protein (CRP) levels on admission, at peak, and at discharge were significantly higher in patients with incomplete recovery. By multivariate logistic regression analysis, lower EF at discharge (odds ratio [OR]: 0.91; 95% confidence interval [CI]: 0.88 to 0.95; p<0.001) and higher CRP levels (OR: 5.56; 95% CI: 1.86 to 16.61; p<0.001) were independent predictors of incomplete recovery at follow-up. The cumulative event-free survival rate according to cardiovascular death was significantly lower in the incomplete recovery group (p<0.001; log-rank test).
Conclusions
We demonstrate that incomplete recovery after takotsubo cardiomyopathy is characterized by a residual systemic inflammation and an increased cardiac mortality at follow-up. Altogether, our findings underline patients with persistent inflammation as a high-risk subgroup, to target in future clinical trials with specific therapies to attenuate inflammation.
Funding Acknowledgement
Type of funding source: None</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/ehjci/ehaa946.1184</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>European heart journal, 2020-11, Vol.41 (Supplement_2)</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Matsushita, K</creatorcontrib><creatorcontrib>Lachmet-Thebaud, L</creatorcontrib><creatorcontrib>Marchandot, B</creatorcontrib><creatorcontrib>Sato, C</creatorcontrib><creatorcontrib>Dagrenat, C</creatorcontrib><creatorcontrib>Greciano, S</creatorcontrib><creatorcontrib>De Poli, F</creatorcontrib><creatorcontrib>Leddet, P</creatorcontrib><creatorcontrib>Trimaille, A</creatorcontrib><creatorcontrib>Heger, J</creatorcontrib><creatorcontrib>Reydel, A</creatorcontrib><creatorcontrib>Trinh, A</creatorcontrib><creatorcontrib>Ohlmann, P</creatorcontrib><creatorcontrib>Jesel, L</creatorcontrib><creatorcontrib>Morel, O</creatorcontrib><title>Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality</title><title>European heart journal</title><description>Abstract
Introduction
Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with takotsubo cardiomyopathy, recent studies have demonstrated the long-lasting functional impairment in those patients.
Purpose
We sought to evaluate the predictors of incomplete recovery in chronic phase and its impact on cardiovascular mortality after takotsubo cardiomyopathy.
Methods
Patients with takotsubo cardiomyopathy between 2008 and 2018 were retrospectively enrolled in three different institutions. Takotsubo cardiomyopathy was diagnosed according to the European Society of Cardiology Heart Failure Association criteria. After exclusion of in-hospital deaths, 407 patients were split into 2 subgroups according whether their LVEF were >50% (recovery group; n=333), or ≤50% (incomplete recovery group; n=74) at follow-up. The primary endpoint was the impact of incomplete recovery on cardiovascular mortality.
Results
Patients with incomplete recovery were more likely to be male, to have dementia, pacemaker, and supraventricular arrhythmia. C-reactive protein (CRP) levels on admission, at peak, and at discharge were significantly higher in patients with incomplete recovery. By multivariate logistic regression analysis, lower EF at discharge (odds ratio [OR]: 0.91; 95% confidence interval [CI]: 0.88 to 0.95; p<0.001) and higher CRP levels (OR: 5.56; 95% CI: 1.86 to 16.61; p<0.001) were independent predictors of incomplete recovery at follow-up. The cumulative event-free survival rate according to cardiovascular death was significantly lower in the incomplete recovery group (p<0.001; log-rank test).
Conclusions
We demonstrate that incomplete recovery after takotsubo cardiomyopathy is characterized by a residual systemic inflammation and an increased cardiac mortality at follow-up. Altogether, our findings underline patients with persistent inflammation as a high-risk subgroup, to target in future clinical trials with specific therapies to attenuate inflammation.
Funding Acknowledgement
Type of funding source: None</description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNkE1OwzAUhC0EEqVwAVa-QMqzYzv2ElX8VKrEpgt20bPjqClJHdlupdyelvYAbGY2883iI-SZwYKBKV_8due6UyIaoRaMaXFDZkxyXhgl5C2ZATOyUEp_35OHlHYAoBVTM2JXexeGsffZ0-hdOPo40dDSjD8hp4MN1GFsujBMYcS8nWiXKNIBdyHS5gTFodvjPp-Ry_CIyR16jHQIMWPf5emR3LXYJ_907TnZvL9tlp_F-utjtXxdF04zUTBVIgjZcg0GLedKaFcKB16WVla6ZAgSrGkq57U10LbKuIpX3nFjuFVVOSf8cutiSCn6th5jN2Ccagb1WVL9J6m-SqrPkk5QcYHCYfzP_hdJH243</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Matsushita, K</creator><creator>Lachmet-Thebaud, L</creator><creator>Marchandot, B</creator><creator>Sato, C</creator><creator>Dagrenat, C</creator><creator>Greciano, S</creator><creator>De Poli, F</creator><creator>Leddet, P</creator><creator>Trimaille, A</creator><creator>Heger, J</creator><creator>Reydel, A</creator><creator>Trinh, A</creator><creator>Ohlmann, P</creator><creator>Jesel, L</creator><creator>Morel, O</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20201101</creationdate><title>Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality</title><author>Matsushita, K ; Lachmet-Thebaud, L ; Marchandot, B ; Sato, C ; Dagrenat, C ; Greciano, S ; De Poli, F ; Leddet, P ; Trimaille, A ; Heger, J ; Reydel, A ; Trinh, A ; Ohlmann, P ; Jesel, L ; Morel, O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c814-163a045f2809ab22648c34c0e53b57831a050b9d7ce8b90ff69c727ec2992b673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsushita, K</creatorcontrib><creatorcontrib>Lachmet-Thebaud, L</creatorcontrib><creatorcontrib>Marchandot, B</creatorcontrib><creatorcontrib>Sato, C</creatorcontrib><creatorcontrib>Dagrenat, C</creatorcontrib><creatorcontrib>Greciano, S</creatorcontrib><creatorcontrib>De Poli, F</creatorcontrib><creatorcontrib>Leddet, P</creatorcontrib><creatorcontrib>Trimaille, A</creatorcontrib><creatorcontrib>Heger, J</creatorcontrib><creatorcontrib>Reydel, A</creatorcontrib><creatorcontrib>Trinh, A</creatorcontrib><creatorcontrib>Ohlmann, P</creatorcontrib><creatorcontrib>Jesel, L</creatorcontrib><creatorcontrib>Morel, O</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsushita, K</au><au>Lachmet-Thebaud, L</au><au>Marchandot, B</au><au>Sato, C</au><au>Dagrenat, C</au><au>Greciano, S</au><au>De Poli, F</au><au>Leddet, P</au><au>Trimaille, A</au><au>Heger, J</au><au>Reydel, A</au><au>Trinh, A</au><au>Ohlmann, P</au><au>Jesel, L</au><au>Morel, O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality</atitle><jtitle>European heart journal</jtitle><date>2020-11-01</date><risdate>2020</risdate><volume>41</volume><issue>Supplement_2</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Abstract
Introduction
Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with takotsubo cardiomyopathy, recent studies have demonstrated the long-lasting functional impairment in those patients.
Purpose
We sought to evaluate the predictors of incomplete recovery in chronic phase and its impact on cardiovascular mortality after takotsubo cardiomyopathy.
Methods
Patients with takotsubo cardiomyopathy between 2008 and 2018 were retrospectively enrolled in three different institutions. Takotsubo cardiomyopathy was diagnosed according to the European Society of Cardiology Heart Failure Association criteria. After exclusion of in-hospital deaths, 407 patients were split into 2 subgroups according whether their LVEF were >50% (recovery group; n=333), or ≤50% (incomplete recovery group; n=74) at follow-up. The primary endpoint was the impact of incomplete recovery on cardiovascular mortality.
Results
Patients with incomplete recovery were more likely to be male, to have dementia, pacemaker, and supraventricular arrhythmia. C-reactive protein (CRP) levels on admission, at peak, and at discharge were significantly higher in patients with incomplete recovery. By multivariate logistic regression analysis, lower EF at discharge (odds ratio [OR]: 0.91; 95% confidence interval [CI]: 0.88 to 0.95; p<0.001) and higher CRP levels (OR: 5.56; 95% CI: 1.86 to 16.61; p<0.001) were independent predictors of incomplete recovery at follow-up. The cumulative event-free survival rate according to cardiovascular death was significantly lower in the incomplete recovery group (p<0.001; log-rank test).
Conclusions
We demonstrate that incomplete recovery after takotsubo cardiomyopathy is characterized by a residual systemic inflammation and an increased cardiac mortality at follow-up. Altogether, our findings underline patients with persistent inflammation as a high-risk subgroup, to target in future clinical trials with specific therapies to attenuate inflammation.
Funding Acknowledgement
Type of funding source: None</abstract><pub>Oxford University Press</pub><doi>10.1093/ehjci/ehaa946.1184</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-668X |
ispartof | European heart journal, 2020-11, Vol.41 (Supplement_2) |
issn | 0195-668X 1522-9645 |
language | eng |
recordid | cdi_crossref_primary_10_1093_ehjci_ehaa946_1184 |
source | Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
title | Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T07%3A02%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incomplete%20recovery%20of%20takotsubo%20cardiomyopathy%20is%20a%20major%20determinant%20of%20cardiovascular%20mortality&rft.jtitle=European%20heart%20journal&rft.au=Matsushita,%20K&rft.date=2020-11-01&rft.volume=41&rft.issue=Supplement_2&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/ehjci/ehaa946.1184&rft_dat=%3Coup_cross%3E10.1093/ehjci/ehaa946.1184%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/ehjci/ehaa946.1184&rfr_iscdi=true |